About the Company
novan, inc. is a clinical-stage biotechnology company focused on leveraging nitric oxide’s natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases. we believe that our ability to conveniently deploy nitric oxide in a solid form, on demand and in localized formulations allows us the potential to significantly improve patient outcomes in a variety of diseases.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $NOVN News
Ligand (LGND) Acquires Certain Assets of Novan for $12.2M
Ligand Pharmaceuticals LGND announced that it has completed the acquisition of certain assets of Novan, Inc. for $12.2 million. As a result, Ligand now has full ownership rights to berdazimer gel ...
Novan (NASDAQ: NOVN)
Novan, Inc. is a medical dermatology company, which engages in the development and commercialization of therapeutic products for skin diseases. It operates through the Commercial Operations and ...
Global Molluscum Contagiosum Treatment Market Set to Reach US$ 4.89 Billion by 2033
Molluscum Contagiosum Treatment Market is projected to expand at a CAGR of 5%, potentially reaching US$ 4.89 billion by the ...
Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI™
Ligand acquired the rights to ZELSUVMI and all the assets related to the NITRICIL technology platform from Novan, Inc. in September 2023. "ZELSUVMI is a highly differentiated product that we ...
Malin Corp plc's Net Worth
This is based on reported shares across multiple companies, which include Poseida Therapeutics, Inc., and Novan, Inc.. Attention insiders: Dive deeper into market movements and stay ahead of the ...
NVN Liquidation Inc NOVNQ
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Warts Therapeutics Market Analysis, Key Segments, Share, Size, Growth Status, and Forecast to 2024 to 2032
Report Ocean recently published a research report titled “Warts Therapeutics Market” 2024 Forecast to 2032 Analysis by Market ...
Inc. 5000 Conference
She spoke at the 2023 Inc. 5000 Conference about the difference between marketing and advertising. At the Inc. 5000 Conference, Howroyd, the first Black woman to build and own a billion-dollar ...
About Inc.com | Everything You Need to Know to Grow and Start Your Business
Inc. is the voice of the American entrepreneur. We inspire, inform, and document the most fascinating people in business: the risk-takers, the innovators, and the ultra-driven go-getters that ...
Macy's, Inc. (M)
Vanguard Small Cap Value Index Fund 4.81M Dec 31, 2023 1.75% 89,121,520 Vanguard Extended Market Index Fund 4.05M Dec 31, 2023 1.47% 75,050,783 Avantis U.S. Small Cap Value Fund 3.32M Dec 31, 2023 ...
Apple Inc.
1 Day AAPL -1.22% DJIA 0.56% S&P 500 -0.88% Technology -5.78% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum ...
Loading the latest forecasts...